Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2020 1
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Patient-reported outcomes and personalised cancer care.
Clinical Oncology Society of Australia (COSA) Patient Reported Outcomes Working Group; Koczwara B, Bonnamy J, Briggs P, Brown B, Butow PN, Chan RJ, Cohn RJ, Girgis A, Jefford M, Jl Joske D, Licqurish S, Mackay G, Saunders CM, Webber K. Clinical Oncology Society of Australia (COSA) Patient Reported Outcomes Working Group, et al. Med J Aust. 2021 May;214(9):406-408.e1. doi: 10.5694/mja2.50893. Epub 2020 Dec 13. Med J Aust. 2021. PMID: 34046907 No abstract available.
Current landscape of cancer survivorship research in Australia.
Morris JN, Crawford-Williams F, Koczwara B, Chan RJ, Vardy J, Lisy K, Iddawela M, Mackay G, Jefford M. Morris JN, et al. Asia Pac J Clin Oncol. 2023 Oct;19(5):e305-e313. doi: 10.1111/ajco.13914. Epub 2023 Jan 19. Asia Pac J Clin Oncol. 2023. PMID: 36658677
Clinical Oncology Society of Australia Position Statement: 2022 update to the safe handling of monoclonal antibodies in healthcare settings.
Ryan M, Lam N, Wright K, Siderov J. Ryan M, et al. Asia Pac J Clin Oncol. 2023 Dec;19(6):723-730. doi: 10.1111/ajco.13943. Epub 2023 Mar 10. Asia Pac J Clin Oncol. 2023. PMID: 36899469
AIM: The aims were to (a) review the scientific literature on occupational risk, including exposure mechanisms and risk assessment, with regards to handling monoclonal antibodies (mABs) in healthcare settings; and (b) update the recommendations in the Clinical Oncology Society of …
AIM: The aims were to (a) review the scientific literature on occupational risk, including exposure mechanisms and risk assessment, with reg …
Study to support the standardization of the prescribing, dispensing and labeling of etoposide formulations in Australia.
Carrington C, Weir J, DO C. Carrington C, et al. Asia Pac J Clin Oncol. 2010 Sep;6(3):173-86. doi: 10.1111/j.1743-7563.2010.01317.x. Asia Pac J Clin Oncol. 2010. PMID: 20887498
METHODS: Cancer care clinicians and pharmacists, identified through their membership of the Clinical Oncological Society of Australia (COSA), were asked to complete an online survey or participate in a telephone interview, about their etoposide prescribing and dispensing p …
METHODS: Cancer care clinicians and pharmacists, identified through their membership of the Clinical Oncological Society of Australia (CO …
Development of guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy.
Carrington C, Stone L, Koczwara B, Searle C. Carrington C, et al. Asia Pac J Clin Oncol. 2010 Sep;6(3):213-9. doi: 10.1111/j.1743-7563.2010.01313.x. Asia Pac J Clin Oncol. 2010. PMID: 20887504
This article reports on the development of multidisciplinary consensus guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy undertaken by a working group of the Clinical Oncological Society of Australia (COSA). METHODS: A working group …
This article reports on the development of multidisciplinary consensus guidelines for the safe prescribing, dispensing and administration of …